Agenus, Inc. (AGEN)
3.91
+0.16
(+4.27%)
USD |
NASDAQ |
Jan 09, 16:00
3.93
+0.02
(+0.51%)
After-Hours: 20:00
Agenus Research and Development Expense (Annual): 155.53M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Inovio Pharmaceuticals, Inc. | 77.22M |
| Cardiff Oncology, Inc. | 36.85M |
| Armata Pharmaceuticals, Inc. | 34.43M |
| Bionano Genomics, Inc. | 24.80M |
| Twist Bioscience Corp. | 80.28M |